Extracellular adenosine triphosphate and adenosine in cancer.
about
A secreted tyrosine kinase acts in the extracellular environmentPurinergic signalling and cancerConcepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapiesCD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppressionCD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growthImportant roles of P2Y receptors in the inflammation and cancer of digestive systemThe role of regulatory T cells in cancer immunologyThe P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.Adenosine A2A receptors intrinsically regulate CD8+ T cells in the tumor microenvironmentAdenosine A2B receptor blockade slows growth of bladder and breast tumors.Infantile Hemangioma Originates From A Dysregulated But Not Fully Transformed Multipotent Stem Cell.Adenosine arrests breast cancer cell motility by A3 receptor stimulation.A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment.Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma.Treatment with a rho kinase inhibitor improves survival from graft-versus-host disease in mice after MHC-haploidentical hematopoietic cell transplantation.Activation of the P2Y1 receptor induces apoptosis and inhibits proliferation of prostate cancer cells.The roles of CD73 in cancerImmune cell regulation by autocrine purinergic signalling.Cellular function and molecular structure of ecto-nucleotidases.Signalling molecules in the urotheliumNTPDase3 and ecto-5'-nucleotidase/CD73 are differentially expressed during mouse bladder cancer progression.Heat-shock protein 70 modulates toxic extracellular α-synuclein oligomers and rescues trans-synaptic toxicity.Adoptive immunotherapy with Cl-IB-MECA-treated CD8+ T cells reduces melanoma growth in miceCharacterization of ectonucleotidases in human medulloblastoma cell lines: ecto-5'NT/CD73 in metastasis as potential prognostic factor.Nucleotide signalling during inflammationBig opportunities for small molecules in immuno-oncology.Growth and metastasis of B16-F10 melanoma cells is not critically dependent on host CD73 expression in mice.Adenosine receptors and renal ischaemia reperfusion injury.CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in miceExtracellular metabolic energetics can promote cancer progressionThe first CD73-instructed supramolecular hydrogel.Ectokinases as novel cancer markers and drug targets in cancer therapy.Fluorescence polarization immunoassays for monitoring nucleoside triphosphate diphosphohydrolase (NTPDase) activity.Selective inhibition of KCa3.1 channels mediates adenosine regulation of the motility of human T cellsAdenosine and protection from acute kidney injury.CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell deathThe therapeutic potential of adenosine triphosphate as an immune modulator in the treatment of HIV/AIDS: a combination approach with HAART.CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma.A Gain-Of-Function Mutation in the Plcg2 Gene Protects Mice from Helicobacter felis-Induced Gastric MALT LymphomaCD73 promotes tumor growth and metastasis
P2860
Q24303065-88AF8C63-5167-4D9E-A87F-7CD6A3402319Q24618782-231844B6-9508-4E28-8C5D-5584AC700ACBQ26781215-2ED9738A-178C-494D-8F76-08093537E5FEQ26801436-AD25F27A-93E1-4BB7-B14A-7135BB74B802Q26823709-2864BC5F-8159-4351-BC04-450C51E71CFEQ26991904-0449A2BB-A03F-4A28-AE21-51B98E792A79Q27006663-C56FC22C-A2F4-4A22-AF18-A2A3342A8B8DQ27304392-E5BF9A65-4022-4A2C-86E3-D02A5F1B39C4Q28250207-3F071715-A422-4254-BB50-A5DC94A2E7C6Q30416420-711FD0DE-DD00-44A5-8313-BAAE9721D085Q30826592-62127179-4BE9-4199-BC2E-C47BD7808CBEQ30829844-E645F0B0-C36C-421C-9224-F4F55A2F3BEFQ33763266-51AB9BC8-BD2A-404E-A8CA-55F7CC0E3A44Q33771631-9A8FF08F-0E52-4D7B-9A9D-DFDA5EF0FD53Q33918485-B3BBDF5D-1A1D-4041-BE98-78325EBE117DQ33919264-6FF72F5C-154F-4096-A077-AE9DB7531ADAQ34003164-821F1E91-75DC-4525-932F-7552158BBA30Q34025783-79E9BD81-C472-41F9-8D80-25CBB7F300BCQ34031794-C6366D89-82D4-43B0-8E78-EC9428A3EDEAQ34080499-CD563995-5329-4BF4-8D42-208F784082EAQ34123241-0DECF4D9-4AB5-49E2-8646-12D379F6E83AQ34421765-6AA7D783-4D99-40E4-B613-8E897FC64857Q34428963-75E94350-502B-4E82-9E18-268CFFF29F1DQ34456325-59B6CBF5-58D2-48B9-AC43-0FE538BE59AEQ34464511-ED1D9CA5-A6CD-43A5-A743-196EB92704D8Q34487689-F1F10B91-45C5-4873-831D-90FF557D4C74Q34695338-8B84EBF1-CE41-450D-BC70-2C575F399B5AQ34735024-82DF685D-1390-4308-B90C-C0C3A972E94EQ35015717-808B9674-5D6E-4B48-8E13-E2DE115245A0Q35033532-379FE1CD-75F0-40E9-9CD4-F4CB4CDF6E65Q35205307-3288B754-A61B-4C53-8CB5-1BEF216E0EECQ35236798-F3D2DA2C-6152-4D34-96BC-092167C5A407Q35394974-18623821-D952-464D-8186-761723BE4093Q35557998-2E898CD6-86DB-4CCB-9A49-F4F0E9B4B154Q35755490-05792365-1C20-4203-8B5E-B19CD654EDDDQ35930211-450937F0-F39E-439D-AB03-BFC7D7564EB0Q35932071-368878DC-5911-4292-AE87-8993627C9164Q35941350-1BF2DD40-952C-4BA9-AD97-B009C709D50EQ35953664-9E4DB600-98DF-48A5-AFD2-AD7B6B5F0957Q36038399-DC741E4B-A275-4DCE-A489-BA32138795FB
P2860
Extracellular adenosine triphosphate and adenosine in cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Extracellular adenosine triphosphate and adenosine in cancer.
@en
Extracellular adenosine triphosphate and adenosine in cancer.
@nl
type
label
Extracellular adenosine triphosphate and adenosine in cancer.
@en
Extracellular adenosine triphosphate and adenosine in cancer.
@nl
prefLabel
Extracellular adenosine triphosphate and adenosine in cancer.
@en
Extracellular adenosine triphosphate and adenosine in cancer.
@nl
P356
P1433
P1476
Extracellular adenosine triphosphate and adenosine in cancer
@en
P2093
P2888
P304
P356
10.1038/ONC.2010.292
P407
P577
2010-07-26T00:00:00Z